Table 1.
Epilepsy-related co-morbidities in patients with tuberous sclerosis complex with epilepsy
| Age (years) | TSC+E (n=209) | |||||||||||||||||||||
| ADHD | Autism | Behavioural disorder | Brain tumour/growth | Dementia | Depression | Intellectual disability | Learning disability | Psychosis | Sleep disorder | Speech and language disorder | ||||||||||||
| n | % (95% CI) | n | % (95% CI) | n | % (95% CI) |
n | % (95% CI) |
n | % (95% CI) |
n | % (95% CI) |
n | % (95% CI) |
n | % (95% CI) |
n | % (95% CI) |
n | % (95% CI) |
n | % (95% CI) |
|
| Total | 9 | (4.3 (1.5 to 7.1) | 37 | 17.7 (12.5 to 22.9) | 41 | 19.6 (14.2 to 25.1) | 33 | 15.8 (10.8 to 20.8) | 13 | 6.2 (2.9 to 9.5) | 30 | 14.4 (9.6 to 19.2) | 19 | 9.1 (5.2 to 13.0) | 112 | 53.6 (46.8 to 60.4) | 7 | 3.4 (0.9 to 5.8) | 28 | 13.4 (8.7 to 18.1) | 33 | 15.8 (10.8 to 20.8) |
| <18 | 7 | (8.6 2.4 to 14.9) | 16 | 19.8 (10.9 to 28.6) | 16 | 19.8 (10.9 to 28.6) | 12 | 14.8 (6.9 to 22.7) | 5 | 6.2 (0.8 to 11.5) | 0 | (0) | 3 | 3.7 (0 to 7.9) | 34 | 42.0 (40.0 to 53.0) | 1 | 1.2 (0 to 3.7) | 10 | 12.4 (5.0 to 19.7) | 9 | 11.1 (4.1 to 18.1) |
| ≥18 | 2) | (1.6 0 to 3.7 | 21 | 16.4 (9.9 to 22.9) | 25 | 19.4 (12.6 to 26.5) | 21 | 16.4 (9.9 to 22.9) | 8 | 6.3 (2.0 to 10.5) | 30 | 23.4 (16.0 to 30.9) | 16 | 12.5 (6.7 to 18.3) | 78 | 60.9 (52.4 to 69.5) | 6 | 4.7 (1.0 to 8.4) | 18 | 14.1 (8.0 to 20.2) | 24 | 18.8 (11.9 to 25.6) |
ADHD, attention-deficit/hyperactivity disorder; TSC+E, tuberous sclerosis complex with epilepsy.